This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • GS-5806 in Hematopoietic Cell Transplant Recipient...
Clinical trial

GS-5806 in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

Read time: 1 mins
Last updated:29th Sep 2014

This study will evaluate the effect of GS-5806 on respiratory syncytial virus (RSV) viral load in autologous or allogeneic hematopoietic cell transplant (HCT) recipients with an acute RSV lower respiratory tract infection (LRTI), the effect of GS-5806 on rates of respiratory failure and all-cause mortality, and pharmacokinetics (PK), safety, and tolerability of GS-5806.

Category Value
Study start date 2014-09-29

View full details